Exposure to Proprotein Convertase Subtilisin/Kexin Type 9...

European Heart Journal 2020 / 11 Vol. 41; Iss. Supplement

Exposure to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the association with neurocognitive side effects: a meta-analysis and meta-regression

Hirsh-Raccah, B, Yanovsky, A, Rotshild, V, Danenberg, H, Eliaz, R, Matok, I
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
41
Journal:
European Heart Journal
DOI:
10.1093/ehjci/ehaa946.3339
Date:
November, 2020
File:
PDF, 80 KB
2020
Conversion to is in progress
Conversion to is failed